Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-32,222
Closed -$136K 1976
2023
Q4
$136K Buy
+32,222
New +$175K ﹤0.01% 1721
2023
Q1
Sell
-17,055
Closed -$103K 1714
2022
Q4
$103K Buy
+17,055
New +$126K 0.01% 1488
2022
Q2
Sell
-38,753
Closed -$760K 1976
2022
Q1
$760K Buy
38,753
+5,157
+15% +$103K 0.03% 828
2021
Q4
$1.15M Buy
+33,596
New +$1.35M 0.05% 542
2021
Q3
Sell
-8,256
Closed -$607K 1701
2021
Q2
$607K Buy
+8,256
New +$825K 0.04% 720

Other funds holding CVAC

Engineers Gate Manager's CVAC Position: Q1 2024 in Review

Engineers Gate Manager sold out of CureVac (CVAC) in Q1 2024, closing a stake of 32,222 shares — an estimated $136K sold.

Engineers Gate Manager first reported a position in CVAC in Q2 2021 and held it in 5 quarters. The position peaked at $1.15M in Q4 2021. 90 funds tracked by Wall St. Rank hold CVAC as of Q1 2024.

  • Engineers Gate Manager reported no remaining CureVac position as of Q1 2024 after selling out during the quarter.
  • Engineers Gate Manager sold 32,222 CureVac shares in Q1 2024, an estimated $136K.
  • Engineers Gate Manager first reported a position in CureVac in Q2 2021 and held it in 5 quarters.
  • Engineers Gate Manager's CureVac position peaked at $1.15M in Q4 2021.
  • 90 funds tracked by Wall St. Rank held CureVac as of Q1 2024.

Based on Engineers Gate Manager's 13F filing for Q1 2024, filed 15 May 2024.